Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases

被引：0
|
作者：
Fabiszewska, S. [1 ]
Derda, E. [1 ]
Szymanska, E. [1 ]
Osiecki, M. [1 ]
Kierkus, J. [1 ]
机构：
[1] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P551
引用
收藏
页码：I498 / I498
页数：1
相关论文
共 50 条
  • [21] Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
    Strigac, Aleksandra
    Caban, Milosz
    Malecka-Wojciesko, Ewa
    Talar-Wojnarowska, Renata
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [22] Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases
    Alayo, Quazim A.
    Khatiwada, Aava
    Patel, Anish
    Zulfiqar, Maria
    Gremida, Anas
    Gutierrez, Alexandra
    Rood, Richard P.
    Ciorba, Matthew A.
    Christophi, George
    Deepak, Parakkal
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : 1698 - 1702
  • [23] Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
    Moens, Annick
    van Hoeve, Karen
    Humblet, Evelien
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dewit, Sophie
    Franchimont, Denis
    Macken, Elisabeth
    Nijs, Jochen
    Posen, Annelies
    Strubbe, Beatrijs
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Ferrante, Marc
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (01): : 12 - 18
  • [24] Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
    Scarozza, Patrizio
    De Cristofaro, Elena
    Scucchi, Ludovica
    Rocchetti, Irene
    Marafini, Irene
    Neri, Benedetto
    Salvatori, Silvia
    Biancone, Livia
    Calabrese, Emma
    Monteleone, Giovanni
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 10
  • [25] Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
    Lynch, Kate D.
    Chapman, Roger W.
    Keshav, Satish
    Montano-Loza, Aldo J.
    Mason, Andrew L.
    Kremer, Andreas E.
    Vetter, Marcel
    de Krijger, Manon
    Ponsioen, Cyriel Y.
    Trivedi, Palak
    Hirschfield, Gideon
    Schramm, Christoph
    Liu, Chung Heng
    Bowlus, Christopher L.
    Estes, Derek J.
    Pratt, Daniel
    Hedin, Charlotte
    Bergquist, Annika
    de Vries, Annemarie C.
    van der Woude, C. Janneke
    Yu, Lei
    Assis, David N.
    Boyer, James
    Ytting, Henriette
    Hallibasic, Emina
    Trauner, Michael
    Marschall, Hanns-Ulrich
    Daretti, Luigi M.
    Marzioni, Marco
    Yimam, Kidist K.
    Perin, Nicola
    Floreani, Annarosa
    Beretta-Piccoli, Benedetta Terziroli
    Rogers, Jennifer K.
    Levy, Cynthia
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 179 - +
  • [26] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
    Christensen, Britt
    Gibson, Peter R.
    Micic, Dejan
    Colman, Ruben J.
    Goeppinger, Sarah R.
    Kassim, Olufemi
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 486 - 493
  • [27] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    [J]. DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [28] Safety and Efficacy of Vedolizumab Use in Older Patients With Inflammatory Bowel Disease
    Shivashankar, Raina
    Aberra, Faten
    Ladd, Antonio Mendoza
    Lichtenstein, Gary R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S404 - S405
  • [29] The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases
    Macaluso, Fabio Salvatore
    Orlando, Rosalba
    Fries, Walter
    Scolaro, Mariangela
    Magnano, Antonio
    Pluchino, Dario
    Cappello, Maria
    Morreale, Gaetano Cristian
    Siringo, Sebastiano
    Privitera, Antonino Carlo
    Ferracane, Concetta
    Belluardo, Nunzio
    Alberghina, Nadia
    Ventimiglia, Marco
    Rizzuto, Giulia
    Renna, Sara
    Cottone, Mario
    Orlando, Ambrogio
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (07) : 675 - 681
  • [30] Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety
    Christensen, Britt
    Colman, Ruben J.
    Micic, Dejan
    Gibson, Peter R.
    Goeppinger, Sarah R.
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 849 - 860
12345